Trevena, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2007-01-01
- Employees
- 23
- Market Cap
- $3.9M
- Website
- http://www.trevena.com
A Study of TRV130 for the Treatment of Pain After Bunionectomy
- First Posted Date
- 2014-04-01
- Last Posted Date
- 2020-09-16
- Lead Sponsor
- Trevena Inc.
- Target Recruit Count
- 333
- Registration Number
- NCT02100748
- Locations
- 🇺🇸
Premier Research, Austin, Texas, United States
🇺🇸Chesapeake Research Group, Pasadena, Maryland, United States
🇺🇸Jean Brown Research, Salt Lake City, Utah, United States
Pharmacokinetics and Pharmacodynamics of TRV130, Morphine, and Placebo in Healthy Subjects
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-03-11
- Last Posted Date
- 2014-03-11
- Lead Sponsor
- Trevena Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT02083315
- Locations
- 🇺🇸
CRI Lifetree, Salt Lake City, Utah, United States
A Study to Explore the Efficacy of TRV027 in Patients Hospitalized for Acute Decompensated Heart Failure
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-10-21
- Last Posted Date
- 2018-07-26
- Lead Sponsor
- Trevena Inc.
- Target Recruit Count
- 620
- Registration Number
- NCT01966601
- Locations
- 🇺🇸
Tennessee Center for Clinical Trials, Tullahoma, Tennessee, United States
🇺🇸Wayne State University, Detroit, Michigan, United States
🇸🇰Research Site, Martin, Slovakia
Single Ascending Dose Study of Intravenous TRV130A in Healthy Adult Males
- First Posted Date
- 2012-01-23
- Last Posted Date
- 2012-08-24
- Lead Sponsor
- Trevena Inc.
- Target Recruit Count
- 74
- Registration Number
- NCT01514578
- Locations
- 🇺🇸
ICON Development Solutions, Omaha, Nebraska, United States
Study to Evaluate TRV120027 on Renal Pharmacodynamics in Patients With Heart Failure and Renal Dysfunction
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-10-03
- Last Posted Date
- 2012-08-27
- Lead Sponsor
- Trevena Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT01444872
- Locations
- 🇺🇸
Orlando Clinical Research Center, Orlando, Florida, United States
🇺🇸DaVita Clinical Research, Minneapolis, Minnesota, United States
🇺🇸Duke Clinical Research Unit, Durham, North Carolina, United States
Study to Evaluate the Effects of TRV120027 in Patients With Heart Failure
- First Posted Date
- 2010-08-24
- Last Posted Date
- 2017-07-11
- Lead Sponsor
- Trevena Inc.
- Target Recruit Count
- 33
- Registration Number
- NCT01187836
- Locations
- 🇨🇿
CZ05, Brno, Czechia
🇨🇿CZ04, Olomouc, Czechia
🇨🇿CZ06, Prague, Czechia
© Copyright 2024. All Rights Reserved by MedPath